09 December 2021

Rutherford Health plc

Directorate Change

Rutherford Health plc (AQSE: RUTH, the "Group"), a healthcare group committed to providing innovative cancer care of the highest quality, announces the appointment of Dr Mark Jackson as the Non-executive Chairman of the Group with effect from 7 December 2021 and a Non-executive Director of the Company with effect from 6 December 2021. Mark worked for many years as a GP practice lead before founding and growing his own successful company. He has also served on the boards of a number of well-known companies in the health and care sectors, including several years as the Chairman of Exemplar Health Care, Deputy Chairman of Allied Healthcare as well as Non-Executive Director at UME Group. Rupert Lowe has completed his term as Chairman and has agreed to remain as a Non-Executive Director and support the Company's new Chairman.

Having now built the business, Mike Moran will be stepping down as Chief Executive Officer (CEO). The company would like to thank Mike for his hard work in building the centres and establishing operational capability.

The intention is for a new CEO to be appointed in early 2022.  An experienced interim, Sean Sullivan, has been appointed as a Chief Restructuring Officer to bridge the intervening period and assist in consolidating our position.  Also in the interim, the Company intends to appoint a strategic advisory firm to support its development of a growth-orientated business plan going forward.

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.